• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,947.72 -10.80
( -0.01%)
Global Indices
Nasdaq
49,922.52 603.26
(1.22%)
Dow Jones
7,387.39 107.17
(1.47%)
Hang Seng
62,916.52 3,403.40
(5.72%)
Nikkei 225
10,442.09 222.98
(2.18%)
Forex
USD-INR
95.18 0.09
(0.09%)
EUR-INR
111.29 -0.04
(-0.04%)
GBP-INR
128.89 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(-0.23%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
17.34
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
299
68.4
EPS(TTM)
Face Value()
Div & Yield %
0.15
10
0
 

hcl technologies ltd
HCL Technologies consolidated net profit rises 4.20% in the March 2026 quarter
Apr 22,2026
Net profit of HCL Technologies rose 4.20% to Rs 4488.00 crore in the quarter ended March 2026 as against Rs 4307.00 crore during the previous quarter ended March 2025. Sales rose 12.35% to Rs 33981.00 crore in the quarter ended March 2026 as against Rs 30246.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 4.30% to Rs 16642.00 crore in the year ended March 2026 as against Rs 17390.00 crore during the previous year ended March 2025. Sales rose 11.18% to Rs 130144.00 crore in the year ended March 2026 as against Rs 117055.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales33981.0030246.00 12 130144.00117055.00 11
OPM %19.7521.43 -20.5621.79 -
PBDT6794.006775.00 0 27413.0027345.00 0
PBT5702.005735.00 -1 23058.0023261.00 -1
NP4488.004307.00 4 16642.0017390.00 -4